Results 181 to 190 of about 15,059 (213)

Metachromatic leukodystrophy: A single‐center longitudinal study of 45 patients

Journal of Inherited Metabolic Disease, 2021
In this study, we characterize the natural course of metachromatic leukodystrophy (MLD), explore intra/inter group differences, and identify biomarkers to monitor disease progression. This is a longitudinal observational study.
F. Fumagalli   +22 more
semanticscholar   +1 more source

Prenatal metachromatic leukodystrophy.

Helvetica paediatrica acta, 1975
In a family with a metachromatic leukodystrophy patient, two further pregnancies at risk were monitored by amnion cell culture. In one case, a normal baby was predicted and born. In the other case, a prenatal deficiency of arylsulfatase A was found. The diagnosis of metachromatic leukodystrophy was confirmed biochemically in various organs of the fetus
Wiesmann, U N   +6 more
openaire   +2 more sources

Hematopoietic stem cell transplantation with mesenchymal stromal cells in children with metachromatic leukodystrophy.

Stem Cells and Development, 2022
Metachromatic leukodystrophy (MLD) is a lysosomal storage disorder primarily affecting the white matter of the nervous system that results from a deficiency of the arylsulfatase A (ARSA).
K. M. Cabanillas Stanchi   +15 more
semanticscholar   +1 more source

Long-Term Effects of Atidarsagene Autotemcel for Metachromatic Leukodystrophy.

New England Journal of Medicine
BACKGROUND Metachromatic leukodystrophy (MLD) is an ultrarare, severe lysosomal storage disorder caused by a deficiency of arylsulfatase A (ARSA). METHODS We treated patients who had MLD with atidarsagene autotemcel (arsa-cel), a hematopoietic stem ...
Francesca Fumagalli   +50 more
semanticscholar   +1 more source

[Metachromatic leukodystrophy].

Neuropsihijatrija, 1969
INFANTILE metachromatic leukodystrophy (MLD) is a genetically determined fatal lipidosis, in which sulfatides (cerebroside sulfates) accumulate in various organs but chiefly affect the white matter of the nervous system.1-3The activity of the enzyme arylsulfatase-A (ASA) is deficient in patients with MLD.
H L, Greene, G, Hug, W K, Schubert
openaire   +4 more sources

A Mutation-Agnostic Hematopoietic Stem Cell Gene Therapy for Metachromatic Leukodystrophy

The CRISPR Journal, 2021
Metachromatic leukodystrophy (MLD) is a rare genetic disorder caused by mutations in the Arylsulfatase-A (ARSA) gene. The enzyme plays a key role in sulfatide metabolism in brain cells, and its deficiency leads to neurodegeneration.
J. Antony   +14 more
semanticscholar   +1 more source

Metachromatic Leukodystrophy

Archives of Neurology, 1975
• A variant of metachromatic leukodystrophy (MLD), Austin disease, is characterized by a multiple isozyme deficiency of arylsulfatase. A 31/2-year-old girl with progressive mental and physical deterioration had decreased activities of arylsulfatases A and B in the leukocytes, shown by acrylamide gel electrophoresis.
openaire   +1 more source

Home - About - Disclaimer - Privacy